Will Oura's market cap be between $7.5B and $10B at market close on IPO day?

Prediction markets put the probability at 10%: Will Oura's market cap be between $7.5B and $10B at market close on IPO day. Currently, markets see this as unlikely (10% YES).

What’s Happening

Health-tracking ring maker Oura Inc. confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission on May 21, 2026, formally initiating its path to an initial public offering. The San Francisco-based company disclosed that the number of shares and the price range have not yet been determined, with the offering expected to proceed only after the SEC completes its review, subject to market conditions. The filing arrived roughly seven months after a $900 million funding round in October 2025 that lifted Oura's private valuation to approximately $11 billion. That $11B private mark sits above the upper bound of this contract, a key reason the question of whether Oura's market cap be between $7.5B and $10B at market close on IPO day currently prices near 10% YES. [Business Wire, May 21]

The valuation backdrop matters because IPO opening-day pricing frequently diverges from the last private round. Oura reported more than four times total revenue growth over the past two fiscal years while reinvesting gross profit into product development, and said it was on pace to surpass five million paid members in the second quarter. Strong fundamentals typically support a premium to the prior private mark, which would push the debut above $10B and settle this contract NO. Conversely, a softer IPO tape or a conservative bankers' range could compress the figure into the $7.5B–$10B band. Historically, recent consumer-hardware and health-tech listings have priced at discounts to peak private valuations amid tighter capital conditions, making the outcome of whether Oura's market cap be between $7.5B and $10B at market close on IPO day genuinely two-sided. [WSJ, May 21]

What comes next is the SEC review cycle, after which Oura will publicly file its S-1 with financials, a proposed share count, and an indicative price range — the first hard data points for calibrating the close-day capitalization. The company has framed the offering around expanding health features on its wearable, which tracks temperature, heart rate and sleep. Until the price range is set, the distance between the $11 billion private valuation and this contract's $7.5B–$10B ceiling remains the dominant variable, and the low YES probability reflects the market pricing a debut at or above the prior round rather than a discount into the band. [MedTech Dive, May 26]

Traded on Polymarket — $58K Volume

Lower-volume market on Polymarket ($58K). Wider spreads expected — enter with limit orders and be aware of slippage risk. Currently 10c YES.